Conditions & Recovery · NY Times Health · August 19, 2026

Moderna, Merck Say mRNA Vaccine Prevents Melanoma From Returning

Moderna and Merck say the experimental vaccine prevented the return and spread of the cancer in high-risk melanoma patients.

Originally published by NY Times Health. We curate and add context; they did the reporting.

Related learning